Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

about

8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers

P2860

Q36503015-2BB31202-9531-456A-8BC8-0D94AC68B604

P2860

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

Item

http://www.wikidata.org/entity/Q42380473

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

@en

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

@nl

type

Item

label

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

@en

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

@nl

prefLabel

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

@en

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

@nl

P1476

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

@en

P2093

Billie J Nowak

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

Lisa S Chen

http://www.w3.org/2001/XMLSchema#string

Mary L Ayres

http://www.w3.org/2001/XMLSchema#string

Michael W Thomas

http://www.w3.org/2001/XMLSchema#string

Rathi N Pillai

http://www.w3.org/2001/XMLSchema#string

Varsha Gandhi

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol

Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)

Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

Overriding imatinib resistance with a novel ABL kinase inhibitor

BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib.

8-Amino-adenosine inhibits multiple mechanisms of transcription.

Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues

P304

2024-2032

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2012.678003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Keating

P577

2012-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22448923

http://www.w3.org/2001/XMLSchema#string

P932

5648543

http://www.w3.org/2001/XMLSchema#string

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

about

P2860

P2860

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932